Fungemia in non-HIV-infected patients: a five-year review

International Journal of Infectious Diseases

Volumn 13, Issue 1, 2009, Pages 90-96

  Anunnatsiri, Siriluck ^a   Chetchotisakd, Ploenchan ^a   Mootsikapun, Piroon ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Candidemia; Fungemia; Non HIV; Thailand

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; ASSISTED VENTILATION; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FUNGEMIA; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; RISK FACTOR; TRICHOSPORON;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; CANDIDA; CANDIDIASIS; CROSS INFECTION; FEMALE; FUNGEMIA; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MYCOSES; RISK FACTORS; THAILAND; TRICHOSPORON; YOUNG ADULT;

EID: 57849160634     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.04.009     Document Type: Article

References (27)

1. Fridkin S.K., and Jarvis W.R. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9 (1996) 499-511
2. Viudes A., Pemán J., Cantón E., Ubeda P., López-Ribot J.L., and Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 21 (2002) 767-774
3. Poikonen E., Lyytikäinen O., Anttila V.J., and Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 9 (2003) 985-990
4. Goldani L.Z., and Mário P.S. Candida tropicalis fungemia in a tertiary care hospital. J Infect 46 (2003) 155-160
5. Alonso-Valle H., Acha O., García-Palomo J.D., Fariñas-Alvarez C., Fernández-Mazarrasa C., and Fariñas M.C. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 22 (2003) 254-257
6. Abi-Said D., Anaissie E., Uzun O., Raad I., Pinzcowski H., and Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24 (1997) 1122-1128
7. Pfaller M.A., Diekema D.J., Jones R.N., Sader H.S., Fluit A.C., Hollis R.J., et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 39 (2001) 3254-3259
8. Pfaller M.A., Diekema D.J., Messer S.A., Boyken L., and Hollis R.J. Activities of fluconazole and voriconazole against 1586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Programm, 2001. J Clin Microbiol 41 (2003) 1440-1446
9. Messer S.A., Jones R.N., and Fritsche T.R. International surveillance of Candida spp and Aspergillus spp: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 44 (2006) 1782-1787
10. Fraser V.J., Jones M., Dunkel J., Storfer S., Medoff G., and Dunagan W.C. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15 (1992) 414-421
11. Jutivorakool K, Suankratay C, Tantawichien T, Chindamporn A. Candidemia in King Chulalongkorn Hospital: an eleven-year review (Abstract). The 29th Annual Meeting of the Infectious Disease Association of Thailand. Prajuabkirikan, Thailand, October 2003.
12. Wingard J.R., Merz W.G., Rinaldi M.G., Johnson T.R., Karp J.E., and Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325 (1991) 1274-1277
13. Persons D.A., Laughlin M., Tanner D., Perfect J., Gockerman J.P., and Hathorn J.W. Fluconazole and Candida krusei fungemia. N Engl J Med 325 (1991) 1315
14. Cheng Y.R., Lin L.C., Young T.G., Liu C.E., Chen C.H., and Tsay R.W. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 39 (2006) 155-161
15. Costa S.F., Marinho I., Araújo E.A., Manrique A.E., Medeiros E.A., and Levin A.S. Nosocomial fungaemia: a 2-year prospective study. J Hosp Infect 45 (2000) 69-72
16. Bassetti M., Trecarichi E.M., Righi E., Sanguinetti M., Bisio F., Posteraro B., et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis 58 (2007) 325-331
17. Weinberger M., Leibovici L., Perez S., Samra Z., Ostfeld I., Levi I., et al. Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61 (2005) 146-154
18. Nucci M., Colombo A.L., Silveira F., Richtmann R., Solomao R., Branchini M.L., et al. Risk factors for death in patients with candidaemia. Infect Control Hosp Epidemiol 19 (1998) 846-850
19. Yamamura D.L., Rotstein C., Nicolle L.E., and Loannou S. Candidaemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society. CMAJ 160 (1999) 493-499
20. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., et al. A prospective observational study of candidaemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 (2003) 634-643
21. Klevay M.J., Ernst E.J., Hollanbaugh J.L., Miller J.G., Pfaller M.A., and Diekema D.J. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis 60 (2007) 273-277
22. Nolla-Salas J., Sitges-Serra A., León-Gil C., Martínez-González J., León-Regidor M.A., Ibáñez-Lucía P., et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23 (1997) 23-30
23. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 (2005) 3640-3645
24. Macphail G.L., Taylor G.D., Buchanan-Chell M., Ross C., Wilson S., and Kureishi A. Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses 45 (2002) 141-145
25. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43 (2006) 25-31
26. Malani A., Hmoud J., Chiu L., Carver P.L., Bielaczyc A., and Kauffman C.A. Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis 41 (2005) 975-981
27. Ben-Abraham R., Keller N., Teodorovitch N., Barzilai A., Harel R., Barzilay Z., et al. Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 49 (2004) 317-323